hiv - Search News

News

FDA approves HIV prevention drug taken

CBS News on MSN · 2h

FDA approves HIV prevention drug taken as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

USA TODAY on MSN · 4h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Associated Press News on MSN · 4h

The world's only twice-a-year shot to prevent HIV could stop transmission -- if people can get it

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how many in the U.S. and abroad will get access to the powerful new option.

2hon MSN

FDA Approves a Twice-Yearly Shot to Prevent HIV

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

mlive on MSN4h

Genesee County offers no-cost HIV testing at June 27 event in Flint

The Genesee County Health Department is offering no-cost testing during National HIV Testing Day at the Genesee Free Medical ...

Fierce Pharma4h

FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study

According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African ...

1d

AIDS, HIV funding in jeopardy as Trump administration seeks to cut millions from global program

In its latest budget request, the administration aims to slash 38 percent, or $2.9 billion, from the U.S. President’s ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results